Evidence map›Paper›PMID 29973487›Full record

ReviewInternational journal of molecular sciences2018

Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and Cancer.

Mirco Ponzoni, Fabio Pastorino, Daniela Di Paolo, Patrizia Perri, Chiara Brignole

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 1 synthesis or guideline pooled it, 145 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. The Multifaceted Role of Macrophages in Biology and Diseases.International journal of molecular sciences · 2025
    Review
  10. Article
  11. Review
  12. Review
  13. Magnetic Hyperthermia in Glioblastoma Multiforme Treatment.International journal of molecular sciences · 2024
    Review
  14. Article
  15. Review
  16. Complete Rescue of HTLV-1Pathogens (Basel, Switzerland) · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Review

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mirco PonzoniLaboratory of Experimental Therapy in Oncology, Istituto Giannina Gaslini, Via G. Gaslini 5, 16147 Genoa, Italy. mircoponzoni@gaslini.org.ORCID 0000-0002-6164-4286
Fabio PastorinoLaboratory of Experimental Therapy in Oncology, Istituto Giannina Gaslini, Via G. Gaslini 5, 16147 Genoa, Italy. fabiopastorino@gaslini.org.ORCID 0000-0002-8312-808X
Daniela Di PaoloLaboratory of Experimental Therapy in Oncology, Istituto Giannina Gaslini, Via G. Gaslini 5, 16147 Genoa, Italy. danieladipaolo@gaslini.org.ORCID 0000-0001-7264-6888
Patrizia PerriLaboratory of Experimental Therapy in Oncology, Istituto Giannina Gaslini, Via G. Gaslini 5, 16147 Genoa, Italy. patriziaperri@gaslini.org.ORCID 0000-0003-2538-8278
Chiara BrignoleLaboratory of Experimental Therapy in Oncology, Istituto Giannina Gaslini, Via G. Gaslini 5, 16147 Genoa, Italy. chiarabrignole@gaslini.org.ORCID 0000-0002-2563-6991
Istituto Giannina Gaslini · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophages, cells belonging to the innate immune system, present a high plasticity grade, being able to change their phenotype in response to environmental stimuli. They play central roles during development, homeostatic tissue processes, tissue repair, and immunity. Furthermore, it is recognized that macrophages are involved in chronic inflammation and that they play central roles in inflammatory diseases and cancer. Due to their large involvement in the pathogenesis of several types of human diseases, macrophages are considered to be relevant therapeutic targets. Nanotechnology-based systems have attracted a lot of attention in this field, gaining a pivotal role as useful moieties to target macrophages in diseased tissues. Among the different approaches that can target macrophages, the most radical is represented by their depletion, commonly obtained by means of clodronate-containing liposomal formulations and/or depleting antibodies. These strategies have produced encouraging results in experimental mouse models. In this review, we focus on macrophage targeting, based on the results so far obtained in preclinical models of inflammatory diseases and cancer. Pros and cons of these therapeutic interventions will be highlighted.

Indexed as

AnimalsClodronic AcidDisease Models, AnimalDrug Delivery SystemsHumansInflammationLiposomesMacrophagesMiceNanotechnologyNeoplasmsClodronic AcidLiposomescancerinflammatory diseasesmacrophage depletionmacrophage targetingnanomedicinepreclinical models

Identifiers

PMID29973487
PMCPMC6073303
OpenAlexW2810417932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.